Aesculape CRO Belgium

Aesculape CRO is a global contract research organization (CRO) specializing in clinical trial management for the oncology sector. The company provides a comprehensive suite of services including regulatory consulting, clinical monitoring, project management, and data management for Phase I through IV trials. Headquartered in Singapore with a major European hub in Belgium, Aesculape CRO serves pharmaceutical and biotechnology clients across the Asia-Pacific and European markets. In September 2021, the company was acquired by SGS, integrating its expertise into the SGS Health Science division to bolster their global clinical research footprint. The acquisition specifically aimed to strengthen SGS's capabilities in the Asia-Pacific region, leveraging Aesculape's established network and local expertise.